Logiscreen

Anika Therapeutics Inc

$14.30
Market Cap 191.63M
ROE -7.7%
Gross Margin 64.2%
Debt/Equity 0.2
Current Ratio 4.5
Revenue QoQ 13.2%
EPS QoQ 0.1%
F-Score 3

About

Anika Therapeutics, Inc., is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-17.83
vs median 32.28
P/B
1.47
vs median 2.77
ROE
-0.08
vs median 0.12

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics